Nfj Investment Group, LLC Repligen Corp Transaction History

Nfj Investment Group, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$162.42 - $220.56 $11.7 Million - $15.9 Million	-72,013 Reduced 95.41%	3,461 $585,000
Q3 2022 Nov 14, 2022	SELL	$160.42 - $256.21 $8.89 Million - $14.2 Million	-55,400 Reduced 42.33%	75,474 $14.4 Million
Q2 2022 Aug 12, 2022	SELL	$140.68 - $188.02 $54,443 - $72,763	-387 Reduced 0.29%	130,874 $21.3 Million
Q1 2022 May 16, 2022	BUY	$161.19 - $257.96 $12.5 Million - $19.9 Million	77,331 Added 143.39%	131,261 $24.7 Million
Q4 2021 Feb 15, 2022	BUY	$247.59 - $304.47 $13.4 Million - $16.4 Million	53,930 New	53,930 $14.3 Million

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Nfj Investment Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Nfj Investment Group, LLC with notifications on news.